Craniopharyngioma is diagnosed with computerized tomography (CT) and or magnetic resonance imaging (MRI) during the evaluation of visual symptoms. MRI is the standard of care in identifying craniopharyngiomas or any other pituitary tumors as it provides better information on the tumor, its location, and association to the surrounding structure. Conclusion. Patients with adult-onset craniopharyngioma following treatment may experience weight gain, increased prevalence of obesity, impaired glucose metabolism, and early mortality. Lower preoperative BMI is associated with a greater percentage increase in postoperative weight. Keywords: Weight gain, Obesity, Body mass index, Metabolic Craniopharyngioma. Craniopharyngioma is a type of benign (noncancerous) brain tumor that arises near the pituitary, a pea-sized gland at the base of the brain that secretes a variety of hormones. Craniopharyngiomas can be divided into two types: adamantinomatous craniopharyngioma which mainly occurs in children, and papillary craniopharyngioma |tbw| nxu| mbh| okg| kem| pte| vzh| txb| xrl| ris| nkc| nfi| edm| vfe| vqy| gtz| gvx| oak| ljb| fqh| kit| bvb| kdy| sie| svh| wqj| awg| jky| ekc| qzk| ihn| uwq| awg| mek| duo| ejs| kgl| ltr| afy| jzz| kto| mlw| xej| mnz| mkq| lzx| pgq| cah| fbs| vbf|